You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 801 to 825 of about 5877
Next 25
10/26/2020
Evolution of radiotherapies for brain tumors - the story of GammaTile Therapy.
10/19/2020
Midatech Pharma PLC Announces Headline Results of MTX110 Phase I DIPG Study
10/15/2020
Musella Foundation Copayment Assistance Program Closed to New patients
10/08/2020
What would YOU do if you were diagnosed with GBM?
10/04/2020
Brain TUmor Webinar Tonight!
Musella Foundation Copay Assistance Program Status
09/29/2020
Musella Foundation Copay Assistance Program is now open!
09/28/2020
xCures announces the launch of a Compassionate Use program for ulixertinib (BVD-523)
09/18/2020
Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer
09/17/2020
Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control
09/14/2020
2nd Annual Brain Tumor TOGETHER and ACTION Day
09/11/2020
Medexus gets Health Canada nod to market tumor imaging material Gleolan for neurosurgery
09/09/2020
New Webinar Added: Assessment of Treatment Response to Established and Novel Therapies in Glioblastoma Patients using Metabolic and Physiologic MR Imaging Techniques
09/02/2020
Return to work following diagnosis of low-grade glioma
08/31/2020
Glioblastoma Utilizes Fatty Acids and Ketone Bodies for Growth Allowing Progression during Ketogenic Diet Therapy
08/29/2020
Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma
08/25/2020
GT Medical Technologies Announces Data Demonstrating Positive Local Control and Safety Outcomes with GammaTile Therapy for Large Brain Metastases
08/24/2020
Prognostic Value of ABO Blood Groups in Patients with Glioblastoma Multiforme
Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas
The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma
A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma
08/23/2020
Ketone-Supressing Drug Combats Rare Brain Cancer in Mice
Northwell neurosurgeon first on Long Island to use Modus V™ 3D exoscope to remove brain tumor
ERC Announces Interim Results from Phase 2 Trial of Immunotherapy ERC1671 (Gliovac) in Recurrent Glioblastoma Patients
08/17/2020
Amazon Smile Fundraiser! Action Required!